CNAT Conatus Pharmaceuticals Inc. — Stock Price and ... Real-time trade and investing ideas on Conatus Pharmaceuticals Inc. CNAT from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC.

Conatus... (CNAT) Stock Quote | Price Chart | Volume Chart View a financial market summary for CNAT including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to CNAT (Conatus Pharmaceuticals Inc.) stock. Conatus Pharmaceuticals Inc. Common Stock (CNAT) Analyst ... Based on analysts offering 12 month price targets for CNAT in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

View the real-time CNAT price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Conatus against related stocks people have also bought like TTNP, VKTX, BIOC, and ONTX. 2,491 people own Conatus on Robinhood on April 2, 2020.

CNAT Price Target | Conatus Pharmaceuticals Stock Forecast ... See Conatus Pharmaceuticals price target based on analysts offering 12 month price targets for Conatus Pharmaceuticals in the last 3 months. Follow CNAT to track price target and stock forecast updates from top wall street analysts. CNAT - Stock quote for CONATUS PHARMACEUTICALS INC. - … View the latest CNAT stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of CONATUS PHARMACEUTICALS INC.. msn back to msn … Conatus Pharmaceuticals Inc. (CNAT) Stock Price, Quote ... Conatus Pharmaceuticals Inc. (CNAT) and Histogen Inc., a privately-held regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today announced the companies have entered into a definitive agreement under which Histogen will merge with a wholly-owned subsidiary of Conatus in an all-stock

Checking the True Picture for Conatus Pharmaceuticals Inc ...

View the latest CNAT stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of CONATUS PHARMACEUTICALS INC.. msn back to msn … Conatus Pharmaceuticals Inc. (CNAT) Stock Price, Quote ... Conatus Pharmaceuticals Inc. (CNAT) and Histogen Inc., a privately-held regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today announced the companies have entered into a definitive agreement under which Histogen will merge with a wholly-owned subsidiary of Conatus in an all-stock

CNAT:NASDAQ CM Stock Quote - Conatus Pharmaceuticals Inc ...

30 Jan 2020 traded on Nasdaq since 2013 and at one point reached a stock price ticker symbol 'CNAT'; there is expected to be a different ticker symbol  11 Feb 2020 ROTH Capital advised investors in its research note published on February 08, 2018, to Buy the CNAT stock while also putting a $20 price  9 Mar 2020 That day the Cowen set price target on the stock to $1. ROTH Capital also rated CNAT as Initiated on February 08, 2018, with its price target  Conatus Pharmaceuticals Inc. (CNAT) Stock Price, Quote ... Conatus (CNAT) delivered earnings and revenue surprises of 83.33% and 54.16%, respectively, for the quarter ended June 2019. CNAT Stock Price | Conatus Pharmaceuticals Inc. Stock ... CNAT | Complete Conatus Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Conatus Pharmaceuticals Inc. (CNAT) Stock Price, Quote ...

CNAT Price Target and Analyst Ratings (Conatus ... Nov 04, 2019 · 1 Wall Street analysts have issued ratings and price targets for Conatus Pharmaceuticals in the last 12 months. Their average twelve-month price target is $1.50, suggesting that the stock has a possible upside of 383.87%. The high price target for CNAT is $1.50 and the low price target for CNAT is … Conatus Pharmaceuticals Inc. (CNAT) Stock Forum ... Find the latest Conatus Pharmaceuticals Inc. (CNAT) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Conatus Pharmaceuticals Inc. (CNAT) Stock Message Board ... Add CNAT Price Alert Hide Sticky Hide Intro Moderator: Search This Board: 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+

Conatus Pharmaceuticals (CNAT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks Apr-15-19 07:30AM Conatus Late-breaker Oral Presentation at EASL Meeting Details Results of ENCORE-PH Phase 2b Clinical Trial in Patients with NASH Cirrhosis and Severe Portal Hypertension GlobeNewswire -34.42%